Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Nona Bio Signs $604 Million License to Discover mAbs for AstraZeneca

publication date: May 23, 2024

Nona Biosciences signed a $604 million license agreement with AstraZeneca to develop preclinical monoclonal antibodies that will be used to create targeted therapies for oncology indications. A global company, Nona offers early development services ranging from target validation and antibody discovery through preclinical research. AstraZeneca will make a $19 million upfront and a $10 million near-term payment, plus $575 million in potential milestones. It is also eligible for option payments on other programs. Nona is a subsidiary of Harbour BioMed, a Boston-Rotterdam-Shanghai company based on its Harbour Mice® antibody technology platform. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here